LBA50 Perioperative Nivolumab (NIVO) V Placebo (PBO) in Patients (pts) with Resectable NSCLC: Clinical Update from the Phase III CheckMate 77T Study

M. Provencio Pulla, M. Awad,T. Cascone,J.D. Spicer, J. He, S. Lu, A. Alexandru, Y. Watanabe, R. Cornelissen, L.D.O. Koch,J. Kuzdzal,J-L. Pujol,P. Hoffknecht, J.E. Gray,C. Coronado Erdmann, J. Neely, V. Devas, S. Bhatia, F. Tanaka

Annals of Oncology（2024）

Cited 0|Views3

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined